Hancock Jaffe Laboratories Inc (HJLI) Stock
HJLI is no longer traded. Hancock Jaffe Laboratories was delisted from the Nasdaq in December 2021.
Prices on this page are historical; the last trade was December 2, 2021 at $6.33.
Hancock Jaffe Laboratories stock price history
HJLI final trading statistics
- Final close
- $6.33
- Final trading day
- Dec 2, 2021
- Market cap at delisting
- $59.92M
- Shares outstanding
- 9.47M
- Final 52-week range
- $4.99 – $17.68
- Avg. volume (final 3 mo.)
- 146,411
- All-time high (split-adj.)
- $131.00 · May 2018
- All-time low (split-adj.)
- $5.02 · May 2021
- Return since IPO
- -95.2%
- Beta
- 1.54
- Book value / share
- $4.80
- Price / book
- 1.32
Hancock Jaffe Laboratories annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2020 | $4.3K | -$9.1K | -$9.49 |
| FY2019 | $31.2K | -$7.6M | -$9.13 |
| FY2018 | $186.6K | -$13.0M | -$33.36 |
| FY2017 | $422.1K | -$7.8M | — |
| FY2016 | $785.9K | -$3.4M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Hancock Jaffe Laboratories Inc
Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.
Hancock Jaffe Laboratories stock FAQ
What happened to Hancock Jaffe Laboratories stock?
Hancock Jaffe Laboratories stock was delisted from the Nasdaq. Its final close was $6.33 on December 2, 2021.
Is HJLI stock still trading?
No. HJLI was delisted from the Nasdaq in December 2021 and no longer trades on a U.S. exchange.
What was the last price of HJLI stock?
HJLI closed at $6.33 on its final trading day, December 2, 2021, for a market value of about $59.92M.
What were Hancock Jaffe Laboratories's revenue and earnings in its last full fiscal year?
Hancock Jaffe Laboratories reported revenue of $4.3K and net income of -$9.1K in fiscal 2020, its last full year as a public company.
When did Hancock Jaffe Laboratories go public?
Hancock Jaffe Laboratories Inc stock began trading on May 31, 2018.